• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葛根素自微乳在比格犬体内的药代动力学及生物利用度

[Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].

作者信息

Chen Xiao-Xin, Yuan Su, Li Geng, Liang You-Ya, Zhou Xiu, Xie Cheng-Shi, Long Chao-Feng

机构信息

Guangzhou University of Traditional Chinese Medicine, Guangzhou 510405, China.

出版信息

Zhong Yao Cai. 2011 May;34(5):750-3.

PMID:21954564
Abstract

OBJECTIVE

To estabolish a quantitative analysis method for pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs.

METHODS

A crossover design was use to detect the pharmacokinetic parameters of Puerarin self-microemulsion and suspension in Beagle dogs. The concentration of Puerarin in plasma was determined with HPLC, the pharmacokinetics parameters and bioavailability was calculated with DAS 2. 1. 1 programs.

RESULTS

T(max) of Puerarin self-microemulsion and suspension were 3.0 h and 2.0 h, C(max) were 2.14 mg/L and 1.061 mg/L, AUC(0-24) were 10.642 mg h/L and 3 mg x h/L, respectively. The bioavailability of Puerarin self-microemulsion relative to Puerarin suspension were 354.73%.

CONCLUSION

Puerarin self-microemulsion can significantly improve the bioavailability in Beagle dogs.

摘要

目的

建立比格犬中葛根素自微乳的药代动力学和生物利用度的定量分析方法。

方法

采用交叉设计检测比格犬中葛根素自微乳和混悬液的药代动力学参数。用高效液相色谱法测定血浆中葛根素的浓度,用DAS 2.1.1程序计算药代动力学参数和生物利用度。

结果

葛根素自微乳和混悬液的T(max)分别为3.0小时和2.0小时,C(max)分别为2.14毫克/升和1.061毫克/升,AUC(0 - 24)分别为10.642毫克·小时/升和3毫克·小时/升。葛根素自微乳相对于葛根素混悬液的生物利用度为354.73%。

结论

葛根素自微乳可显著提高比格犬的生物利用度。

相似文献

1
[Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].葛根素自微乳在比格犬体内的药代动力学及生物利用度
Zhong Yao Cai. 2011 May;34(5):750-3.
2
Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.通过体外自乳化性能评价和体内药代动力学研究对葛根素自乳化制剂进行处方优化
Yao Xue Xue Bao. 2007 Aug;42(8):886-91.
3
Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.葛根素自微乳载药口服缓控释微丸的制备与评价。
Int J Pharm. 2012 May 10;427(2):337-44. doi: 10.1016/j.ijpharm.2012.02.013. Epub 2012 Feb 16.
4
Enhanced oral bioavailability of puerarin using microemulsion vehicle.使用微乳载体提高葛根素的口服生物利用度。
Drug Dev Ind Pharm. 2009 Feb;35(2):138-44. doi: 10.1080/03639040801973495.
5
Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.葛根素固体脂质纳米粒经口服给药后的药代动力学、组织分布及相对生物利用度。
Int J Pharm. 2011 May 30;410(1-2):138-44. doi: 10.1016/j.ijpharm.2011.02.064. Epub 2011 Mar 15.
6
[Effect of decoction method on pharmacokinetics of puerarin in dogs].[煎煮方法对葛根素在犬体内药代动力学的影响]
Zhong Yao Cai. 2010 Sep;33(9):1442-4.
7
Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets.高效液相色谱法测定犬血浆中葛根素含量及缓释片相对生物利用度研究
J Pharm Biomed Anal. 2006 May 3;41(2):549-53. doi: 10.1016/j.jpba.2005.11.041. Epub 2006 Jan 18.
8
Formulation development and pharmacokinetics of puerarin self-emulsifying drug delivery systems.葛根素自乳化药物递送系统的制剂开发与药代动力学
PDA J Pharm Sci Technol. 2007 Jan-Feb;61(1):37-43.
9
[Preparation of puerarin liposome and its oral absorption in rat].葛根素脂质体的制备及其在大鼠体内的口服吸收
Zhong Yao Cai. 2007 Aug;30(8):970-3.
10
[Study on pharmacokinetics of puerarin in rats following different methods of administration of Tongqiao Sanyu prescription].[不同给药方式下通窍三萸方中葛根素在大鼠体内的药代动力学研究]
Zhongguo Zhong Yao Za Zhi. 2011 Sep;36(17):2347-9.